Pfizer Share Price

₹ 3,847.40

-₹17.00 (-0.44%)
1D
Last updated 13 Nov, 2026, 15:56 IST
NSE: PFIZER
|
Pharmaceuticals

Pfizer Share Price Today

As of 14 Nov 2026, Pfizer share price is ₹3,847.40. The stock opened at ₹3,884.00, compared to its previous close of ₹3,864.40. During today's trading session, Pfizer share price moved in the range of ₹3,829.50 to ₹3,885.00, with an average price of ₹3,857.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,589.00 and a high of ₹5,257.00. On the performance front, Pfizer share price has declined by 16.61% over the last six months and is down 23.72% on a year-on-year basis.

Share price over the last 1 day fell from 3872.20 to 3857.00, ranging between 3835.40 and 3882.90.
₹3,829.50
0.44% down today
₹3,885.00
1D LOW
1D HIGH

Pfizer Stock Insights

Stock Performance
UnderperformingUnderperforming Nifty by 21.48 % in last 1 yr
Shareholding Pattern
DIIDII decreased stake by 8.44%
Shareholding Pattern
FIIFII decreased stake by 1.27%
Pfizer stock performance
Open₹3,884.00
High₹3,885.00
Low₹3,829.50
Prev. close₹3,864.40
Pfizer trading activity
Volume12,669
Average traded price₹3,857.61
Last traded time03:56:38 13 Nov
Last traded quantity1
Circuit
L
H
₹3,091.60
₹4,637.20
52-week
L
H
₹3,589.00
₹5,257.00
Mkt Cap Cr
17,676.01
P/E
20.57
P/B
4.03
ROA
33.25%
ROE
19.78%
ROCE
27.27%
Quick Ratio
5.31
EV/EBITDA
12.09

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Pfizer has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Pfizer appears overvalued compared to its peers
Earnings: 1 out of 5, Very Poor
Earnings
Very Poor
Pfizer revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,52,706.5241.215.079.61%13.79%18.65%2.3123.9
Divis Laboratories3,03,961.5290.716.9515.31%18.69%23.83%3.560.87
Torrent Pharmaceuticals1,79,493.6984.499.654.7%11.42%11.37%0.7534.37
Laurus Labs1,29,410.1898.1321.5711.58%22.11%20.91%0.6854.64
Zydus Lifesciences1,20,249.0927.954.327.63%15.1%14.86%0.9116.02
Dr. Reddy's Laboratories1,15,768.6441.952.984.79%7.21%8.58%1.3519.4
Cipla1,13,912.2239.923.226.6%8.18%10.8%2.521.66
Mankind Pharma1,09,746.0848.086.197.82%12.76%14.68%0.7426.62
Aurobindo Pharma1,03,855.7126.052.646.46%10.13%12.76%1.1512.68
Lupin92,098.8117.643.8313.08%21.65%24.54%1.4210.36

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Pfizer Company Background

ISIN
INE182A01018
Sector Market Cap
₹ 17,676.01 Cr

Pfizer Limited (Pfizer) is an India-based multinational pharmaceutical company focusing on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. Pfizer’s Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approved for administering to individuals of all ages against pneumococcal disease, an infection caused by streptococcus pneumoniae bacteria. Internal Medicine portfolio includes approximately 17 specialties and seven therapy areas, including respiratory, multivitamin and multimineral, gastrointestinal, pain, neuroscience, cardiovascular and women’s healthcare. Pfizer Hospital Business Unit focuses on providing advanced anti-infectives to institutions such as hospitals and nursing homes. Inflammation and Immunology focuses on discovering and developing novel therapeutics for chronic autoimmune diseases. Its brands include Prevenar13, CorexDX, Dolonex, Enbrel, Becosules and Folvite, among others.

Pfizer Financial Highlights

  • Revenue: Pfizer reported revenue of ₹867.69 crore in FY09 vs ₹982.61 crore in FY08. It showed a decrease of 11.70% on a yearly basis.
  • Operating Profit: Pfizer reported an operating profit of ₹210.01 crore in FY09 vs ₹419.13 crore in FY08. It showed a decrease of 49.89% on a year-on-year basis.
  • Net Profit: Pfizer reported a net profit of ₹137.12 crore in FY09 vs ₹299.58 crore in FY08. It showed a decrease of 54.23% on a yearly basis.

Pfizer Quarterly Result Highlights

  • Pfizer reported revenue of ₹774.19 crore in Sep 2026, compared with ₹698.01 crore in Jun 2026, representing an increase of 10.91% on a quarter-on-quarter (QoQ) basis.
  • Pfizer reported an operating profit of ₹422.83 crore in Sep 2026, compared with ₹276.68 crore in Jun 2026, representing an increase of 52.82% on a quarter-on-quarter (QoQ) basis.
  • Pfizer reported a profit of ₹313.25 crore in Sep 2026, compared with ₹204.47 crore in Jun 2026, reflecting an increase of 53.20% on a QoQ basis.
  • The earnings per share (EPS) of Pfizer stood at ₹157.92 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
63.92%
FII
1.63%
Other DII
4.69%
Retail and other
16.92%
Mutual funds
12.83%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.71%
Mar 20262.81%
Jun 20261.65%
Sep 20261.63%

Pfizer Investment Returns

1 day
-0.44%
1 week
-0.22%
1 month
-5.08%
1 year
-23.72%
3 years
-1.63%
5 years
-24.99%

Pfizer Share Price History

Pfizer share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
13 Nov 26
₹3,884.00 / ₹3,847.40
-0.44%
12 Nov 26
₹3,909.00 / ₹3,864.40
-0.74%
11 Nov 26
₹3,960.00 / ₹3,893.30
-0.63%
09 Nov 26
₹3,915.00 / ₹3,917.90
+0.36%
Show more

Pfizer Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsNov 2006Nov 2007Nov 2008Nov 2009
Revenue769.81,019.76982.61867.69
Operating profit162.64451.34419.13210.01
Net profit106.33340299.58137.12

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,519.65₹2,281.35₹2,193.17₹2,424.76
Other Income₹187.95₹172.25₹180.51₹101.05
Total Revenue₹2,707.60₹2,453.60₹2,373.68₹2,525.81
Total Expenses₹1,682.77₹1,610.32₹1,635.56₹1,734.80
Profit Before Tax₹975.67₹1,016.09₹746.07₹824.01
Tax₹253.24₹248.49₹194.74₹200.08
Profit After Tax₹722.43₹767.60₹551.33₹623.93
EPS - Basic₹157.92₹167.79₹119.22₹136.38
EPS - Diluted₹157.92₹167.79₹120.51₹136.38

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹975.67₹1,016.09₹746.07₹824.01
Income before WC changes₹912.85₹770.52₹656.75₹692.75
Change in Assets-₹12.27₹7.23-₹89.91₹85.03
Change in Liabilities₹52.46₹38.22-₹156.18-₹119.52
Change in WC₹40.19₹45.45-₹246.09-₹34.49
Cash flow from Operations₹967.57₹659.75₹256.84₹355.68
Cash flow from Investing-₹561.67-₹71.34₹53.70-₹36.05
Cash flow from Financing-₹798.31-₹205.34-₹235.14-₹345.79
Total Cash Flow-₹392.41₹383.07₹75.40-₹26.16
Cash (Start of the year)₹495.07₹112.00₹36.60₹62.76
Cash (End of the year)₹102.66₹495.07₹112.00₹36.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,118.66₹1,398.26₹1,490.97₹1,475.64
Current Assets₹3,803.22₹3,512.85₹2,737.81₹2,525.09
Total Assets₹4,921.88₹4,911.11₹4,228.78₹4,000.73
Current Liabilities₹627.48₹569.51₹546.56₹657.35
Net Current Asset₹3,175.74₹2,943.34₹2,191.25₹1,867.74
Non-Current Liabilities₹91.50₹124.19₹86.68₹136.08
Equity Capital₹4,202.90₹4,217.41₹3,595.54₹3,207.30
Total Equity & Liabilities₹4,921.88₹4,911.11₹4,228.78₹4,000.73
* All values are in INR Crore
Pfizer market depth
Bid quantityBid priceAsk priceAsk quantity
003847.435
0000
0000
0000
0000
Total bid quantity0
Total ask quantity35
Pfizer technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
48.67
Neutral
ATR (14)
101.01
Neutral
STOCH(9,6)
64.86
Neutral
STOCH RSI (14)
71.7
Neutral
ADX(9)
21.88
Bearish
UO(9)
46.68
Neutral
ROC(12)
3.03
Bullish
WillR(14)
-33.18
Neutral
Period
Simple value
Exponential vaue
5D
3885.36
3864.65
10D
3843.47
3846
20D
3784.61
3839.18
50D
3946.64
3988.2
100D
4331.45
4206.31
Volume trend — traded volume by day
13 Nov0L
12 Nov0L
11 Nov0L
9 Nov0L
8 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Pfizer
Pharmaceuticals
Add Stock
Add Another

Pfizer Returns Calculator

Ex-date: 17 Jul 2026

Pfizer Latest News

2 months ago
Pfizer, PCBL, Data Patterns shares spurt amid surge in volumes; check full list
3 months ago
Q3 Results Today: BSE, Zydus Lifesciences, Aurobindo Pharma, Pfizer, GSK, Ramco Cements, PNG, others to post earnings on Feb 9; check list
Showing news item 1 of 2

Top Gainers

POWERINDIA Share Price
₹31595.00
+3050 (+10.68%)
AMBER Share Price
₹6772.00
+563 (+9.07%)
ANURAS Share Price
₹1300.60
+98.8 (+8.22%)
ITI Share Price
₹268.07
+17.06 (+6.8%)
ACI Share Price
₹455.05
+28.35 (+6.64%)
See more

Top Losers

ASTRAZEN Share Price
₹6031.50
-407 (-6.32%)
MAHSEAMLES Share Price
₹540.90
-29.7 (-5.21%)
FDC Share Price
₹371.45
-18.95 (-4.85%)
MANYAVAR Share Price
₹473.85
-23.3 (-4.69%)
NETWORK18 Share Price
₹26.95
-1.3 (-4.6%)
See more

Pfizer Share Price FAQs

Please be aware that Pfizer stock prices are subject to continuous fluctuations due to various factors.